{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:05:16Z","timestamp":1790384716074,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.revmed.2013.10.336","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T14:51:21Z","timestamp":1385045481000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Maladies auto-immunes et cancers. Premi\u00e8re partie\u00a0: cancers au cours des maladies auto-immunes et de leur traitement"],"prefix":"10.1016","volume":"35","author":[{"given":"F.","family":"Pasquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pavic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ninet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2013.10.336_bib0005","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2013.10.336_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.revmed.2013.10.336_bib0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0002-9343(64)90101-9","article-title":"The development of malignant lymphoma in the course of Sj\u00f6gren's syndrome","volume":"36","author":"Talal","year":"1964","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2013.10.336_bib0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clin.1994.1123","article-title":"Sj\u00f6gren's syndrome: autoimmune epithelitis","volume":"72","author":"Moutsopoulos","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.revmed.2013.10.336_bib0025","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2013.10.336_bib0030","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sj\u00f6gren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2013.10.336_bib0035","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sj\u00f6gren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sj\u00f6gren's Syndrome","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 1","key":"10.1016\/j.revmed.2013.10.336_bib0045","first-page":"67","article-title":"Lymphoproliferative disorders in patients with Sj\u00f6gren's syndrome","volume":"3","author":"Sugai","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2013.10.336_bib0050","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0046-8177(91)90126-A","article-title":"Monocytoid B-cell lymphoma in patients with Sj\u00f6gren's syndrome: a clinicopathologic study of 13\u00a0patients","volume":"22","author":"Shin","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1016\/j.revmed.2013.10.336_bib0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0248-8663(97)84399-8","article-title":"Maladie de Hodgkin avec marqueurs cellulaires du virus Epstein-Barr compliquant l\u2019\u00e9volution d\u2019un syndrome de Gougerot-Sj\u00f6gren","volume":"18","author":"Gaches","year":"1997","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.10.336_bib0060","first-page":"174","article-title":"Epstein-Barr virus study in malignant lymphoma in Sj\u00f6gren's syndrome","volume":"69","author":"Hirose","year":"1999","journal-title":"Int J Hematol"},{"key":"10.1016\/j.revmed.2013.10.336_bib0065","first-page":"1744","article-title":"cell lymphoma with Sj\u00f6gren's syndrome: a report with immunologic and genotypic studies","volume":"18","author":"Chevalier","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2013.10.336_bib0070","first-page":"1674","article-title":"Local cytokine expression in the progression toward B cell malignancy in Sj\u00f6gren's syndrome","volume":"22","author":"De Vita","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2013.10.336_bib0075","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","article-title":"Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sj\u00f6gren's syndrome","volume":"39","author":"Tzioufas","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0080","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/ard.60.11.1007","article-title":"Lymphomas complicating Sj\u00f6gren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells","volume":"60","author":"Mariette","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2013.10.336_bib0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","article-title":"Incidence of cancer among patients with rheumatoid arthritis","volume":"85","author":"Gridley","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.revmed.2013.10.336_bib0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9343(85)90240-2","article-title":"Cancer and rheumatoid arthritis: epidemiologic considerations","volume":"78","author":"Prior","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2013.10.336_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/ar2404","article-title":"A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis","volume":"10","author":"Smitten","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2013.10.336_bib0100","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/art.30134","article-title":"The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan","volume":"63","author":"Chen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0105","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.10939","article-title":"Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives","volume":"48","author":"Ekstr\u00f6m","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0110","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk","volume":"32","author":"Mellemkjaer","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.revmed.2013.10.336_bib0115","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0120","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"Mariette","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2013.10.336_bib0125","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","article-title":"Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis","volume":"328","author":"Kamel","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2013.10.336_bib0130","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","article-title":"Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases","volume":"14","author":"Salloum","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2013.10.336_bib0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1191\/0961203302lu182rr","article-title":"Systemic lupus erythematosus and cancer: associated or not?","volume":"11","author":"Abu-Shakra","year":"2002","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.revmed.2013.10.336_bib0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.1780170407","article-title":"Malignancy in a series of 70\u00a0patients with systemic lupus erythematosus","volume":"17","author":"Canoso","year":"1974","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V27.4.435.435","article-title":"Autoimmune disease in NZB-Bl mice. II. Autoimmunity and malignant lymphoma","volume":"27","author":"Mellors","year":"1966","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2013.10.336_bib0150","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/art.1780390625","article-title":"Malignancy in systemic lupus erythematosus","volume":"39","author":"Abu-Shakra","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1191\/096120301678646128","article-title":"Systemic lupus erythematosus and the risk of malignancy","volume":"10","author":"Cibere","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2013.10.336_bib0160","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/rheumatology\/39.10.1147","article-title":"Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276\u00a0patients under long-term review","volume":"39","author":"Sultan","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2013.10.336_bib0165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.1780220816","article-title":"Immunoblastic sarcoma with features of Sj\u00f6gren's syndrome and systemic lupus erythematosus in a patient with immunoblastic lymphadenopathy","volume":"22","author":"Pierce","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0170","first-page":"589","article-title":"Immunoblastic sarcoma in patients with systemic lupus erythematosus-like disorders","volume":"107","author":"Stevanovic","year":"1983","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.revmed.2013.10.336_bib0175","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/gast.2002.36585","article-title":"Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis","volume":"123","author":"Askling","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2013.10.336_bib0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.revmed.2003.10.001","article-title":"La maladie c\u0153liaque de l\u2019adulte\u00a0: aspects nouveaux","volume":"25","author":"Lepers","year":"2004","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.10.336_bib0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-199509000-00012","article-title":"Celiac-associated lymphoma. A single institution experience of 30\u00a0cases in the combination chemotherapy era","volume":"2","author":"Egan","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.revmed.2013.10.336_bib0190","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.revmed.2009.04.009","article-title":"Maladie c\u0153liaque","volume":"31","author":"Malamut","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.10.336_bib0195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2013.10.336_bib0200","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2013.10.336_bib0205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/qjmed\/hcg058","article-title":"Primary small-bowel malignancy in the UK and its association with coeliac disease","volume":"96","author":"Howdle","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2013.10.336_bib0210","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gut.30.3.333","article-title":"Malignancy in coeliac disease \u2013 effect of a gluten free diet","volume":"30","author":"Holmes","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.revmed.2013.10.336_bib0215","first-page":"217","article-title":"Increased risk of malignancy in patients with systemic lupus erythematosus","volume":"46","author":"Ramsey-Goldman","year":"1998","journal-title":"J Investig Med"},{"key":"10.1016\/j.revmed.2013.10.336_bib0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.revmed.2012.10.374","article-title":"Reynolds syndrome revealing a malignant thymoma","volume":"34","author":"Michaud","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.10.336_bib0225","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/rheumatology\/39.9.1044","article-title":"Thymoma-associated systemic lupus erythematosus, exacerbating after thymectomy. A case report and review of the literature","volume":"39","author":"Boonen","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2013.10.336_bib0230","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0248-8663(01)00374-5","article-title":"Thymome et lupus \u00e9ryth\u00e9mateux diss\u00e9min\u00e9. \u00c0 propos de deux nouvelles observations et revue de la litt\u00e9rature","volume":"22","author":"Genty","year":"2001","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.10.336_bib0235","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11926-002-0045-6","article-title":"Malignancy and systemic lupus erythematosus","volume":"4","author":"Bernatsky","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.revmed.2013.10.336_bib0240","first-page":"1478","article-title":"Risk of malignancy in women with systemic lupus erythematosus","volume":"22","author":"Sweeney","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2013.10.336_bib0245","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/1097-0142(195311)6:6<1147::AID-CNCR2820060605>3.0.CO;2-L","article-title":"Pulmonary fibrosis and terminal bronchiolar (alveolar-cell) carcinoma in scleroderma","volume":"6","author":"Zatuchni","year":"1953","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2013.10.336_bib0250","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0248-8663(96)82683-X","article-title":"Scl\u00e9rodermie syst\u00e9mique et cancers\u00a0: 21\u00a0cas et revue de la litt\u00e9rature","volume":"17","author":"Bielefeld","year":"1996","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.10.336_bib0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00296-001-0141-3","article-title":"Lung cancer associated with several connective tissue diseases: with a review of literature","volume":"21","author":"Yang","year":"2001","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2013.10.336_bib0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","article-title":"Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies","volume":"52","author":"Bonifazi","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2013.10.336_bib0265","first-page":"1113","article-title":"A cohort study of cancer incidence in systemic sclerosis","volume":"33","author":"Derk","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2013.10.336_bib0270","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/rheumatology\/ker110","article-title":"Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study","volume":"50","author":"Wipff","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2013.10.336_bib0275","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1097-0274(200007)38:1<8::AID-AJIM2>3.0.CO;2-#","article-title":"Silica, silicosis, and lung cancer: a risk assessment","volume":"38","author":"Finkelstein","year":"2000","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.revmed.2013.10.336_bib0280","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1378\/chest.121.4.1278","article-title":"Association of malignancy with diseases causing interstitial pulmonary changes","volume":"121","author":"Bouros","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2013.10.336_bib0285","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0248-8663(97)80804-1","article-title":"Scl\u00e9rodermie syst\u00e9mique et cancer. Recherche de facteurs pr\u00e9dictifs chez 123\u00a0patients scl\u00e9rodermiques","volume":"18","author":"Kyndt","year":"1997","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.10.336_bib0290","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1186\/ar3544","article-title":"Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort","volume":"13","author":"Nikpour","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2013.10.336_bib0295","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3899\/jrheum.101144","article-title":"Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies","volume":"38","author":"Airo\u2019","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2013.10.336_bib0300","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/ard.62.8.697","article-title":"Risk of cancer in patients with scleroderma","volume":"62","author":"Pearson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2013.10.336_bib0305","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/ard.47.12.988","article-title":"Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20-year follow-up study","volume":"47","author":"Silman","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2013.10.336_bib0310","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2013.10.336_bib0315","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2013.10.336_bib0320","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pds.2046","article-title":"Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data","volume":"20","author":"Askling","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.revmed.2013.10.336_bib0325","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/art.22864","article-title":"Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0330","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1002\/art.24941","article-title":"Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?","volume":"60","author":"Askling","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0335","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.autrev.2009.07.006","article-title":"Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry","volume":"9","author":"Pallavicini","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2013.10.336_bib0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semarthrit.2010.08.005","article-title":"Cancer in patients with rheumatic diseases exposed to TNF antagonists","volume":"41","author":"Carmona","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0345","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/rheumatology\/ken242","article-title":"The British Society for Rheumatology Biologics Register: 6\u00a0years on","volume":"47","author":"Hyrich","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2013.10.336_bib0350","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","article-title":"Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2013.10.336_bib0355","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","article-title":"The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562\u00a0patients during 89,710\u00a0person-years of observation","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0360","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.22056","article-title":"Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis","volume":"54","author":"Setoguchi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.10.336_bib0365","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1136\/ard.2008.097527","article-title":"Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment","volume":"68","author":"Simon","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2013.10.336_bib0370","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2217\/ijr.10.52","article-title":"Efficacy and safety of abatacept therapy for rheumatoid arthritis in routine clinical practice","volume":"5","author":"Schiff","year":"2010","journal-title":"International Journal of Clinical Rheumatology"},{"key":"10.1016\/j.revmed.2013.10.336_bib0375","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/rheumatology\/keq368","article-title":"Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries","volume":"50","author":"Mariette","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2013.10.336_bib0380","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.30158","volume":"63","author":"Kremer","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 10","key":"10.1016\/j.revmed.2013.10.336_bib0385","first-page":"1955","article-title":"Long-term safety and tolerability of tocilizumab treatment in patients with rheumatoid arthritis and a treatment duration of 2.4\u00a0years","volume":"60","author":"Van Vollenhoven","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313010631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313010631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:57Z","timestamp":1759336377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866313010631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0248866313010631"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2013.10.336","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maladies auto-immunes et cancers. Premi\u00e8re partie\u00a0: cancers au cours des maladies auto-immunes et de leur traitement","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2013.10.336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}